Fig. 3
From: Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer
Synergy scores of the top candidate pretreatments after 9-day pretreatment. The figure shows the median scores of three replicate experiments for each measurement where higher score (red) represents synergy with doxorubicin and rituximab, and lower score (green) antagonism. For example, entinostat shows high synergy in all cell lines except Riva-I, whereas belinostat has the highest synergetic killing effect in Riva-I but less so in the other cells lines. Grey boxes represent untested combinations